OBJECTIVE: Angiogenesis is the formation of new blood vessels through endothelial cell sprouting. This process requires the mitogen-activated protein kinases, signaling molecules that are negatively regulated by the mitogen-activated protein kinase phosphatase-1 (MKP-1). The purpose of this study was to evaluate the role of MKP-1 in neovascularization in vivo and identify associated mechanisms in endothelial cells. APPROACH AND RESULTS: We used murine hindlimb ischemia as a model system to evaluate the role of MKP-1 in angiogenic growth, remodeling, and arteriogenesis in vivo. Genomic deletion of MKP-1 blunted angiogenesis in the distal hindlimb and microvascular arteriogenesis in the proximal hindlimb. In vitro, endothelial MKP-1 depletion/deletion abrogated vascular endothelial growth factor-induced migration and tube formation, and reduced proliferation. These observations establish MKP-1 as a positive mediator of angiogenesis and contrast with the canonical function of MKP-1 as a mitogen-activated protein kinase phosphatase, implying an alternative mechanism for MKP-1-mediated angiogenesis. Cloning and sequencing of MKP-1-bound chromatin identified localization of MKP-1 to exonic DNA of the angiogenic chemokine fractalkine, and MKP-1 depletion reduced histone H3 serine 10 dephosphorylation on this DNA locus and blocked fractalkine expression. In vivo, MKP-1 deletion abrogated ischemia-induced fractalkine expression and macrophage and T-lymphocyte infiltration in distal hindlimbs, whereas fractalkine delivery to ischemic hindlimbs rescued the effect of MKP-1 deletion on neovascular hindlimb recovery. CONCLUSIONS: MKP-1 promoted angiogenic and arteriogenic neovascular growth, potentially through dephosphorylation of histone H3 serine 10 on coding-region DNA to control transcription of angiogenic genes, such as fractalkine. These observations reveal a novel function for MKP-1 and identify MKP-1 as a potential therapeutic target.
OBJECTIVE: Angiogenesis is the formation of new blood vessels through endothelial cell sprouting. This process requires the mitogen-activated protein kinases, signaling molecules that are negatively regulated by the mitogen-activated protein kinase phosphatase-1 (MKP-1). The purpose of this study was to evaluate the role of MKP-1 in neovascularization in vivo and identify associated mechanisms in endothelial cells. APPROACH AND RESULTS: We used murine hindlimb ischemia as a model system to evaluate the role of MKP-1 in angiogenic growth, remodeling, and arteriogenesis in vivo. Genomic deletion of MKP-1 blunted angiogenesis in the distal hindlimb and microvascular arteriogenesis in the proximal hindlimb. In vitro, endothelial MKP-1 depletion/deletion abrogated vascular endothelial growth factor-induced migration and tube formation, and reduced proliferation. These observations establish MKP-1 as a positive mediator of angiogenesis and contrast with the canonical function of MKP-1 as a mitogen-activated protein kinase phosphatase, implying an alternative mechanism for MKP-1-mediated angiogenesis. Cloning and sequencing of MKP-1-bound chromatin identified localization of MKP-1 to exonic DNA of the angiogenic chemokine fractalkine, and MKP-1 depletion reduced histone H3 serine 10 dephosphorylation on this DNA locus and blocked fractalkine expression. In vivo, MKP-1 deletion abrogated ischemia-induced fractalkine expression and macrophage and T-lymphocyte infiltration in distal hindlimbs, whereas fractalkine delivery to ischemic hindlimbs rescued the effect of MKP-1 deletion on neovascular hindlimb recovery. CONCLUSIONS:MKP-1 promoted angiogenic and arteriogenic neovascular growth, potentially through dephosphorylation of histone H3 serine 10 on coding-region DNA to control transcription of angiogenic genes, such as fractalkine. These observations reveal a novel function for MKP-1 and identify MKP-1 as a potential therapeutic target.
Authors: Craig L Duvall; W Robert Taylor; Daiana Weiss; Robert E Guldberg Journal: Am J Physiol Heart Circ Physiol Date: 2004-03-11 Impact factor: 4.733
Authors: J F Bazan; K B Bacon; G Hardiman; W Wang; K Soo; D Rossi; D R Greaves; A Zlotnik; T J Schall Journal: Nature Date: 1997-02-13 Impact factor: 49.962
Authors: S Giroux; M Tremblay; D Bernard; J F Cardin-Girard; S Aubry; L Larouche; S Rousseau; J Huot; J Landry; L Jeannotte; J Charron Journal: Curr Biol Date: 1999-04-08 Impact factor: 10.834
Authors: Nina C Weber; Signe B Blumenthal; Thomas Hartung; Angelika M Vollmar; Alexandra K Kiemer Journal: J Leukoc Biol Date: 2003-08-11 Impact factor: 4.962
Authors: Hope B Pearson; Devon E Mason; Christopher D Kegelman; Liming Zhao; James H Dawahare; Melissa A Kacena; Joel D Boerckel Journal: Tissue Eng Part A Date: 2019-06-14 Impact factor: 3.845
Authors: Devon E Mason; Joseph M Collins; James H Dawahare; Trung Dung Nguyen; Yang Lin; Sherry L Voytik-Harbin; Pinar Zorlutuna; Mervin C Yoder; Joel D Boerckel Journal: J Cell Biol Date: 2019-02-08 Impact factor: 10.539
Authors: N Macías-Segura; J E Castañeda-Delgado; Y Bastian; D Santiago-Algarra; J D Castillo-Ortiz; A L Alemán-Navarro; E Jaime-Sánchez; M Gomez-Moreno; C A Saucedo-Toral; Edgar E Lara-Ramírez; M Zapata-Zuñiga; L Enciso-Moreno; R González-Amaro; C Ramos-Remus; J A Enciso-Moreno Journal: PLoS One Date: 2018-03-27 Impact factor: 3.240